| 000 | 01777 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517002408.0 | ||
| 264 | 0 | _c20151030 | |
| 008 | 201510s 0 0 eng d | ||
| 022 | _a1872-9061 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBerden, F A C | |
| 245 | 0 | 0 |
_aDutch guidance for the treatment of chronic hepatitis C virus infection in a new therapeutic era. _h[electronic resource] |
| 260 |
_bThe Netherlands journal of medicine _cOct 2014 |
||
| 300 |
_a388-400 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xpharmacology |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xcomplications |
| 650 | 0 | 4 |
_aHeterocyclic Compounds, 3-Ring _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xcomplications |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aProtease Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aSimeprevir |
| 650 | 0 | 4 | _aSofosbuvir |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 650 | 0 | 4 |
_aUridine Monophosphate _xanalogs & derivatives |
| 700 | 1 | _aKievit, W | |
| 700 | 1 | _aBaak, L C | |
| 700 | 1 | _aBakker, C M | |
| 700 | 1 | _aBeuers, U | |
| 700 | 1 | _aBoucher, C A B | |
| 700 | 1 | _aBrouwer, J T | |
| 700 | 1 | _aBurger, D M | |
| 700 | 1 | _avan Erpecum, K J L | |
| 700 | 1 | _avan Hoek, B | |
| 700 | 1 | _aHoepelman, A I M | |
| 700 | 1 | _aHonkoop, P | |
| 700 | 1 | _aKerbert-Dreteler, M J | |
| 700 | 1 | _ade Knegt, R J | |
| 700 | 1 | _aKoek, G H | |
| 700 | 1 | _avan Nieuwkerk, C M J | |
| 700 | 1 | _avan Soest, H | |
| 700 | 1 | _aTan, A C I T L | |
| 700 | 1 | _aVrolijk, J M | |
| 700 | 1 | _aDrenth, J P H | |
| 773 | 0 |
_tThe Netherlands journal of medicine _gvol. 72 _gno. 8 _gp. 388-400 |
|
| 999 |
_c24345500 _d24345500 |
||